Some state laws linked to lower incidence of e-cigarette use

Some state laws linked to lower incidence of e-cigarette use

Vaping among teens doubles in a year says MTF report -- People were 14% less likely to use e-cigarettes in states where laws prohibited their sale to persons under age 21. This is also the law that is in force in the fewest number of states-;only California, Hawaii, and the District of Columbia have implemented age restrictions. However, a new rule from the U.S. Food and Drug Administration now makes it illegal to sell e-cigarettes to anyone under the age of 21 in the U.S. --People were 11% less likely to use e-cigarettes in states in which the devices and their refills were taxed, laws that have been implemented in seven states. --People were 10% less likely to use e-cigarettes in states where they are prohibited for use in indoor areas of private workplaces, restaurants, and bars. Ten states have this law in place. --People were 10% less likely to use e-cigarettes in states where laws required retailers be licensed to sell them. This law is in place in 15 states. Not every law was as successful, though. Regulations prohibiting self-service retail displays of e-cigarettes was not significantly associated with e-cigarette use. This is also the most commonly implemented law regarding e-cigarettes, in place in 26 states. Bao cautions that the survey is observational and the data does not establish a definite cause-and-effect relationship between laws and reduced usage. He says that the magnitude of associations between state laws and e-cigarette use was modest. However, because state laws are applied to the general population, the population-wide health effects of exposure to those state laws would be substantial. He also says that the findings are generally consistent with the finding of previous studies for state laws regarding conventional cigarettes and conventional cigarette use. Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More